LYB vs TTRX · P/E 21, rev $16.37B vs $187.1M cap
LyondellBasell Industries NV (LYB) versus Turn Therapeutics Inc. Common Stock (TTRX) — a side-by-side from cached financials, not a winner call.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Turn Therapeutics Inc. Common Stock (TTRX) is a biotechnology company listed on NASDAQ.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
TTRX does not have a complete income-statement cache yet.
LYB currently screens at market cap $19.93B and trailing P/E 21.5. TTRX currently screens at market cap $187.1M.
Not investment advice. Open the LYB and TTRX stock pages for the full models.
Not investment advice.